NCT03967717

Brief Summary

The aim of the study is the characterization of parameters from medical history, physical examination and diagnostics, which correlate with and could be used to predict diuretic efficacy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
29 days until next milestone

Study Start

First participant enrolled

June 28, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2022

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2022

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

2.7 years

First QC Date

May 27, 2019

Last Update Submit

November 28, 2023

Conditions

Keywords

Edema

Outcome Measures

Primary Outcomes (2)

  • Multivariable regression analysis at 6±1 hours

    Multivariable regression analysis at 6±1 hours from timepoint of first diuretic administration in the emergency department. Independent variables: diuretic dose, clinical characteristics, serum creatinine, serum urea, urine sodium, urine conductivity and others. The dependent variable will be urine volume 6±1h after diuretic therapy or the difference in weight before diuretic administration and 6±1 hours afterwards.

    6±1 hours from timepoint of first diuretic administration in the emergency department

  • Multivariable regression analysis 24 hours time course

    Multivariable regression analysis over 24 hours time course from timepoint of first diuretic administration in the emergency department. Independent variables: diuretic dose, clinical characteristics, serum creatinine, serum urea, urine sodium, urine conductivity and others. The dependent variable will be urine volume at different timepoints (e.g. 6h, 18h, 24h) within a maximum of 24 hours after first diuretic administration

    24 hours time course from timepoint of first diuretic administration in the emergency departmentnistration

Study Arms (1)

Patients with edematous states

Patients with edematous states receive standard of care diuretic.

Other: Characterization of parameters of medical history, examination and diagnostics.

Interventions

Patients receive standard of care diuretics. The study only collects data to characterize parameters of medical history, examination and diagnostics.

Patients with edematous states

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inclusion of patients with edematous states of cardiac or renal genesis. Patients with liver cirrhosis and in need of ascites puncture and/or thoracentesis are excluded.

You may qualify if:

  • Age over 18 years.
  • Edema (peripheral and/or pulmonal) of cardiac or renal genesis.

You may not qualify if:

  • Persons who are in a dependency/employment relationship with the investigators.
  • Accommodation in an institution by judicial or administrative order.
  • Patients in need of ascites puncture and/or thoracentesis on admission day.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Cologne

Cologne, 50937, Germany

Location

MeSH Terms

Conditions

Edema

Interventions

Restraint, Physical

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior ControlTherapeuticsImmobilizationInvestigative Techniques

Study Officials

  • Volker Burst, MD

    University Hospital of Cologne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 27, 2019

First Posted

May 30, 2019

Study Start

June 28, 2019

Primary Completion

March 18, 2022

Study Completion

April 4, 2022

Last Updated

November 29, 2023

Record last verified: 2023-11

Locations